Sally Crossing AM Award 2022: Celebrating advances in breast cancer research
The 2022 Sally Crossing AM Award for an Outstanding outcome in cancer research has been awarded to Professor Elgene Lim for his Celebrating advances in breast cancer research.
‘The award recognises the outcomes achieved by Professor Lim arising from research previously funded by Cancer Council, with strong consumer involvement, and which has improved the lives of those affected by cancer.’
This prestigious award has been made possible through the generosity of the Belalberi Foundation, a foundation established by the family of the late Sally Crossing AM (1946-2016). Sally was a pioneer and tireless advocate for patient-centred medicine, and the first consumer appointed to the Cancer Council Board. She advocated strongly and continuously for training in consumer advocacy and for the inclusion of consumers in research. Cancer Council NSW and Cancer Voices NSW acknowledge the extraordinary support of the Belalberi Foundation and the Crossing family in conferring this award. Read more here